Michael Matson

Stock Analyst at Needham

(2.69)
# 1,877
Out of 4,789 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return

Stocks Rated by Michael Matson

Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408$423
Current: $140.30
Upside: +201.50%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.95
Upside: +1,194.96%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $105.45
Upside: -49.74%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $73.39
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $222.30
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $101.24
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $39.03
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $373.30
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $14.49
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $61.38
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $62.25
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $1.09
Upside: -
Upgrades: Buy
Price Target: n/a
Current: $48.11
Upside: -